Epinastine
- Generic Name
- Epinastine
- Brand Names
- Elestat
- Drug Type
- Small Molecule
- Chemical Formula
- C16H15N3
- CAS Number
- 80012-43-7
- Unique Ingredient Identifier
- Q13WX941EF
- Background
Epinastine is used for the prevention of itching associated with allergic conjunctivitis. It has a multi-action effect that inhibits the allergic response in 3 ways: 1. stabilizes mast cells by preventing mast cell degranulation to control the allergic response, 2. prevents histamine binding to both the H1- and H2-receptors to stop itching and provide lastin...
- Indication
For the prevention of itching associated with allergic conjunctivitis.
- Associated Conditions
- Allergic Conjunctivitis (AC)
- Associated Therapies
- -
Epinastine + Pseudoephedrine SR (Slow Release) Versus Epinastine Alone in Patients With Perennial Allergic Rhinitis
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2014-07-08
- Last Posted Date
- 2014-07-14
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 101
- Registration Number
- NCT02182518
Epinastine and Pseudoephedrine Fixed Combination Compared to Separate Administration in Healthy Volunteers
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2014-07-08
- Last Posted Date
- 2014-07-14
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 25
- Registration Number
- NCT02182531
Study of Two Marketed Ocular Anti-Allergy Medications in Subjects With Allergic Conjunctivitis
- First Posted Date
- 2007-09-26
- Last Posted Date
- 2015-05-13
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 79
- Registration Number
- NCT00534794
- Locations
- 🇺🇸
Ophthalmic Consultants of Boston, Boston, Massachusetts, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath